Literature DB >> 9673255

Phospholipid composition of purified Chlamydia trachomatis mimics that of the eucaryotic host cell.

G M Hatch1, G McClarty.   

Abstract

Chlamydia trachomatis is an obligate intracellular eubacterial parasite capable of infecting a wide range of eucaryotic host cells. Purified chlamydiae contain several lipids typically found in eucaryotes, and it has been established that eucaryotic lipids are transported from the host cell to the parasite. In this report, we examine the phospholipid composition of C. trachomatis purified from host cells grown under a variety of conditions in which the cellular phospholipid composition was altered. A mutant CHO cell line, with a thermolabile CDP-choline synthetase, was used to show that decreased host cell phosphatidylcholine levels had no significant effect on C. trachomatis growth. However, less phosphatidylcholine was transported to the parasite and purified elementary bodies contained decreased levels of phosphatidylcholine. Brefeldin A, fumonisin B1, and exogenous sphingomyelinase were used to alter levels of host cell sphingomyelin. None of the agents had a significant effect on C. trachomatis replication. Treatment with fumonisin B1 and exogenous sphingomyelinase resulted in decreased levels of host cell sphingomyelin. This had no effect on glycerophospholipid trafficking to chlamydiae; however, sphingomyelin trafficking was reduced and elementary bodies purified from treated cells had reduced sphingomyelin content. Exposure to brefeldin A, which had no adverse effect on chlamydia growth, resulted in an increase in cellular levels of sphingomyelin and a concomitant increase in the amount of sphingomyelin in purified chlamydiae. Under the experimental conditions used, brefeldin A treatment had only a small effect on sphingomyelin trafficking to the host cell surface or to C. trachomatis. Thus, the final phospholipid composition of purified C. trachomatis mimics that of the host cell in which it is grown.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9673255      PMCID: PMC108408     

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  42 in total

Review 1.  Intracellular transport of ceramide and its metabolites at the Golgi complex: insights from short-chain analogs.

Authors:  A G Rosenwald; R E Pagano
Journal:  Adv Lipid Res       Date:  1993

2.  Thermolabile CDP-choline synthetase in an animal cell mutant defective in lecithin formation.

Authors:  J D Esko; M M Wermuth; C R Raetz
Journal:  J Biol Chem       Date:  1981-07-25       Impact factor: 5.157

3.  CD8+ T lymphocyte-mediated lysis of Chlamydia-infected L cells using an endogenous antigen pathway.

Authors:  P R Beatty; R S Stephens
Journal:  J Immunol       Date:  1994-11-15       Impact factor: 5.422

4.  Differential roles of de novo sphingolipid biosynthesis and turnover in the "burst" of free sphingosine and sphinganine, and their 1-phosphates and N-acyl-derivatives, that occurs upon changing the medium of cells in culture.

Authors:  E R Smith; A H Merrill
Journal:  J Biol Chem       Date:  1995-08-11       Impact factor: 5.157

5.  Brefeldin A-induced increase of sphingomyelin synthesis. Assay for the action of the antibiotic in mammalian cells.

Authors:  A Brüning; A Karrenbauer; E Schnabel; F T Wieland
Journal:  J Biol Chem       Date:  1992-03-15       Impact factor: 5.157

6.  Autoradiographic detection of animal cell membrane mutants altered in phosphatidylcholine synthesis.

Authors:  J D Esko; C R Raetz
Journal:  Proc Natl Acad Sci U S A       Date:  1980-09       Impact factor: 11.205

Review 7.  Iso- and anteiso-fatty acids in bacteria: biosynthesis, function, and taxonomic significance.

Authors:  T Kaneda
Journal:  Microbiol Rev       Date:  1991-06

8.  Cardiolipin biosynthesis in the isolated heart.

Authors:  G M Hatch
Journal:  Biochem J       Date:  1994-01-01       Impact factor: 3.857

9.  Sphingolipids and glycoproteins are differentially trafficked to the Chlamydia trachomatis inclusion.

Authors:  M A Scidmore; E R Fischer; T Hackstadt
Journal:  J Cell Biol       Date:  1996-07       Impact factor: 10.539

Review 10.  Brefeldin A: insights into the control of membrane traffic and organelle structure.

Authors:  R D Klausner; J G Donaldson; J Lippincott-Schwartz
Journal:  J Cell Biol       Date:  1992-03       Impact factor: 10.539

View more
  33 in total

1.  Chlamydia pneumoniae infected macrophages exhibit enhanced plasma membrane fluidity and show increased adherence to endothelial cells.

Authors:  Anthony A Azenabor; Godwin Job; Olanrewaju O Adedokun
Journal:  Mol Cell Biochem       Date:  2005-01       Impact factor: 3.396

2.  Biological characterization of Chlamydia trachomatis plasticity zone MACPF domain family protein CT153.

Authors:  Lacey D Taylor; David E Nelson; David W Dorward; William M Whitmire; Harlan D Caldwell
Journal:  Infect Immun       Date:  2010-03-29       Impact factor: 3.441

3.  Type II fatty acid synthesis is essential for the replication of Chlamydia trachomatis.

Authors:  Jiangwei Yao; Yasser M Abdelrahman; Rosanna M Robertson; John V Cox; Robert J Belland; Stephen W White; Charles O Rock
Journal:  J Biol Chem       Date:  2014-06-23       Impact factor: 5.157

Review 4.  Exogenous fatty acid metabolism in bacteria.

Authors:  Jiangwei Yao; Charles O Rock
Journal:  Biochimie       Date:  2017-06-28       Impact factor: 4.079

5.  Chlamydia trachomatis Relies on Autonomous Phospholipid Synthesis for Membrane Biogenesis.

Authors:  Jiangwei Yao; Philip T Cherian; Matthew W Frank; Charles O Rock
Journal:  J Biol Chem       Date:  2015-05-20       Impact factor: 5.157

6.  The broad-spectrum antiviral compound ST-669 restricts chlamydial inclusion development and bacterial growth and localizes to host cell lipid droplets within treated cells.

Authors:  Kelsi M Sandoz; William G Valiant; Steven G Eriksen; Dennis E Hruby; Robert D Allen; Daniel D Rockey
Journal:  Antimicrob Agents Chemother       Date:  2014-04-28       Impact factor: 5.191

Review 7.  Targeting bacterial membrane function: an underexploited mechanism for treating persistent infections.

Authors:  Julian G Hurdle; Alex J O'Neill; Ian Chopra; Richard E Lee
Journal:  Nat Rev Microbiol       Date:  2011-01       Impact factor: 60.633

Review 8.  Lipid acquisition by intracellular Chlamydiae.

Authors:  Cherilyn A Elwell; Joanne N Engel
Journal:  Cell Microbiol       Date:  2012-04-17       Impact factor: 3.715

Review 9.  Acquisition of nutrients by Chlamydiae: unique challenges of living in an intracellular compartment.

Authors:  Hector Alex Saka; Raphael H Valdivia
Journal:  Curr Opin Microbiol       Date:  2009-12-16       Impact factor: 7.934

10.  Golgi-dependent transport of cholesterol to the Chlamydia trachomatis inclusion.

Authors:  Reynaldo A Carabeo; David J Mead; Ted Hackstadt
Journal:  Proc Natl Acad Sci U S A       Date:  2003-05-12       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.